Shanghai Pharmaceuticals Holding Co Ltd
S1R
Company Profile
Business description
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.
Contact
No. 200 Taicang Road
Shanghai Pharmaceutical Building
Shanghai200020
CHNT: +86 2163730908
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2025
Employees
49,402
Stocks News & Analysis
stocks
Market too pessimistic about unloved ASX health care share
Our analysts believe a long-term margin recovery is underway.
stocks
Two overvalued ASX shares to avoid
Both shares trade at a significant premium to our fair value.
stocks
Materially undervalued ASX tech share
Long reinvestment runway supports our thesis on ASX technology company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,919.00 | 13.20 | 0.15% |
| CAC 40 | 8,025.80 | 66.13 | 0.83% |
| DAX 40 | 23,464.63 | 225.45 | 0.97% |
| Dow JONES (US) | 47,112.45 | 664.18 | 1.43% |
| FTSE 100 | 9,609.53 | 74.62 | 0.78% |
| HKSE | 25,894.55 | 178.05 | 0.69% |
| NASDAQ | 23,025.59 | 153.59 | 0.67% |
| Nikkei 225 | 49,245.51 | 585.99 | 1.20% |
| NZX 50 Index | 13,638.50 | 158.07 | 1.17% |
| S&P 500 | 6,765.88 | 60.76 | 0.91% |
| S&P/ASX 200 | 8,628.70 | 12.70 | 0.15% |
| SSE Composite Index | 3,870.02 | 33.26 | 0.87% |